Sawai Pharmaceutical Co., Ltd. operates in the Pharmaceutical preparations sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Sawai Pharmaceutical Co., Ltd. with three other
companies in this sector in Japan:
KYORIN Holdings, Incorporation
sales of 119.48 billion Japanese Yen [US$1.15 billion]
of which 99%
was Pharmaceutical Business),
Tsumura & Co
(112.63 billion Japanese Yen [US$1.08 billion]
of which 100%
was Pharmaceutical Items), and
Kobayashi Pharmaceutical Co Ltd
(137.21 billion Japanese Yen [US$1.32 billion]
of which 78%
was Domestic Manufacture And Sale Of Househo).
Sawai Pharmaceutical Co., Ltd. reported sales of ¥123.49 billion (US$1.19 billion)
March of 2016.
increase of 17.1%
versus 2015, when the company's sales were ¥105.45 billion.
Sales at Sawai Pharmaceutical Co., Ltd. have increased during each of the previous five years
(and since 2011, sales have increased a total of 93%).